F9M-24680-15208 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-28
Registered in v-safe
2022-06-28
Dose 1 — Moderna
2022-06-28
Health check-in — day 0, dose 1, under 3
Feeling: Good · Sleepiness

Under 3 check-in
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-03
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-04
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-05
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-12
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-19
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-26
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-08-02
Dose 2 — Moderna
2022-12-27
Survey response — 6 months, dose 1, under 3
MedDRA: Conjunctivitis, Ear infection, Nasopharyngitis, Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school

Free text: Various colds, RSV, ear infection, pink eye, etc.

MedDRA releases: 2024-11 · check-in free text available
2023-01-05
Dose 3 — Moderna
2023-01-06
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · Fever · None

Under 3 check-in
2023-01-07
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2023-01-08
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2023-01-11
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2023-01-12
Health check-in — day 7, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2023-01-19
Survey response — day 14, dose 3, under 3
MedDRA: Cough, Nasopharyngitis, Rhinorrhoea, Sneezing — Feeling: Fair

MedDRA releases: 2024-11
2023-01-28
Survey response — day 21, dose 3, under 3
MedDRA: Cough, Nasopharyngitis — Feeling: Good

MedDRA releases: 2024-11
2023-02-02
Survey response — day 28, dose 3, under 3
MedDRA: Cough, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Fair

MedDRA releases: 2024-11
2023-02-09
Health check-in — day 35, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-02-16
Survey response — day 42, dose 3, under 3
MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Good

MedDRA releases: 2024-11
2023-04-06
Survey response — 3 months, dose 3, under 3
MedDRA: Gastroenteritis viral, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-28	Moderna	No
2	2022-08-02	Moderna	No
3	2023-01-05	Moderna	No

Free text

Release 12 (Under 3) — 6 months, dose 1, under 3

2022-12-27

Symptoms: Various colds, RSV, ear infection, pink eye, etc.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Conjunctivitis	·	·	✓
SD	Cough	·	·	✓
SD	Ear infection	·	·	✓
SD	Gastroenteritis viral	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Sneezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release